Cargando…

Evidence against dopamine D1/D2 receptor heteromers

Hetero-oligomers of G-protein-coupled receptors have become the subject of intense investigation because their purported potential to manifest signaling and pharmacological properties that differ from the component receptors makes them highly attractive for the development of more selective pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Frederick, Aliya L., Yano, Hideaki, Trifilieff, Pierre, Vishwasrao, Harshad D., Biezonski, Dominik, Mészáros, József, Sibley, David R., Kellendonk, Christoph, Sonntag, Kai C., Graham, Devon L., Colbran, Roger J., Stanwood, Gregg D., Javitch, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492915/
https://www.ncbi.nlm.nih.gov/pubmed/25560761
http://dx.doi.org/10.1038/mp.2014.166
_version_ 1782379825298669568
author Frederick, Aliya L.
Yano, Hideaki
Trifilieff, Pierre
Vishwasrao, Harshad D.
Biezonski, Dominik
Mészáros, József
Sibley, David R.
Kellendonk, Christoph
Sonntag, Kai C.
Graham, Devon L.
Colbran, Roger J.
Stanwood, Gregg D.
Javitch, Jonathan A.
author_facet Frederick, Aliya L.
Yano, Hideaki
Trifilieff, Pierre
Vishwasrao, Harshad D.
Biezonski, Dominik
Mészáros, József
Sibley, David R.
Kellendonk, Christoph
Sonntag, Kai C.
Graham, Devon L.
Colbran, Roger J.
Stanwood, Gregg D.
Javitch, Jonathan A.
author_sort Frederick, Aliya L.
collection PubMed
description Hetero-oligomers of G-protein-coupled receptors have become the subject of intense investigation because their purported potential to manifest signaling and pharmacological properties that differ from the component receptors makes them highly attractive for the development of more selective pharmacological treatments. In particular, dopamine D1 and D2 receptors have been proposed to form hetero-oligomers that couple to G(αq) proteins, and SKF83959 has been proposed to act as a biased agonist that selectively engages these receptor complexes to activate G(αq) and thus phospholipase C. D1/D2 heteromers have been proposed as relevant to the pathophysiology and treatment of depression and schizophrenia. We used in vitro bioluminescence resonance energy transfer (BRET), ex vivo analyses of receptor localization and proximity in brain slices, and behavioral assays in mice to characterize signaling from these putative dimers/oligomers. We were unable to detect G(αq) or G(α11) protein coupling to homomers or heteromers of D1 or D2 receptors using a variety of biosensors. SKF83959-induced locomotor and grooming behaviors were eliminated in D(1) receptor knockout mice, verifying a key role for D1-like receptor activation. In contrast, SKF83959-induced motor responses were intact in D2 receptor and G(αq) knockout mice, as well as in knock-in mice expressing a mutant Ala(286)-CaMKIIα, that cannot autophosphorylate to become active. Moreover, we found that in the shell of the nucleus accumbens, even in neurons in which D1 and D2 receptor promoters are both active, the receptor proteins are segregated and do not form complexes. These data are not compatible with SKF83959 signaling through G(αq) or through a D1–D2 heteromer and challenge the existence of such a signaling complex in the adult animals that we used for our studies.
format Online
Article
Text
id pubmed-4492915
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-44929152016-05-01 Evidence against dopamine D1/D2 receptor heteromers Frederick, Aliya L. Yano, Hideaki Trifilieff, Pierre Vishwasrao, Harshad D. Biezonski, Dominik Mészáros, József Sibley, David R. Kellendonk, Christoph Sonntag, Kai C. Graham, Devon L. Colbran, Roger J. Stanwood, Gregg D. Javitch, Jonathan A. Mol Psychiatry Article Hetero-oligomers of G-protein-coupled receptors have become the subject of intense investigation because their purported potential to manifest signaling and pharmacological properties that differ from the component receptors makes them highly attractive for the development of more selective pharmacological treatments. In particular, dopamine D1 and D2 receptors have been proposed to form hetero-oligomers that couple to G(αq) proteins, and SKF83959 has been proposed to act as a biased agonist that selectively engages these receptor complexes to activate G(αq) and thus phospholipase C. D1/D2 heteromers have been proposed as relevant to the pathophysiology and treatment of depression and schizophrenia. We used in vitro bioluminescence resonance energy transfer (BRET), ex vivo analyses of receptor localization and proximity in brain slices, and behavioral assays in mice to characterize signaling from these putative dimers/oligomers. We were unable to detect G(αq) or G(α11) protein coupling to homomers or heteromers of D1 or D2 receptors using a variety of biosensors. SKF83959-induced locomotor and grooming behaviors were eliminated in D(1) receptor knockout mice, verifying a key role for D1-like receptor activation. In contrast, SKF83959-induced motor responses were intact in D2 receptor and G(αq) knockout mice, as well as in knock-in mice expressing a mutant Ala(286)-CaMKIIα, that cannot autophosphorylate to become active. Moreover, we found that in the shell of the nucleus accumbens, even in neurons in which D1 and D2 receptor promoters are both active, the receptor proteins are segregated and do not form complexes. These data are not compatible with SKF83959 signaling through G(αq) or through a D1–D2 heteromer and challenge the existence of such a signaling complex in the adult animals that we used for our studies. 2015-01-06 2015-11 /pmc/articles/PMC4492915/ /pubmed/25560761 http://dx.doi.org/10.1038/mp.2014.166 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Frederick, Aliya L.
Yano, Hideaki
Trifilieff, Pierre
Vishwasrao, Harshad D.
Biezonski, Dominik
Mészáros, József
Sibley, David R.
Kellendonk, Christoph
Sonntag, Kai C.
Graham, Devon L.
Colbran, Roger J.
Stanwood, Gregg D.
Javitch, Jonathan A.
Evidence against dopamine D1/D2 receptor heteromers
title Evidence against dopamine D1/D2 receptor heteromers
title_full Evidence against dopamine D1/D2 receptor heteromers
title_fullStr Evidence against dopamine D1/D2 receptor heteromers
title_full_unstemmed Evidence against dopamine D1/D2 receptor heteromers
title_short Evidence against dopamine D1/D2 receptor heteromers
title_sort evidence against dopamine d1/d2 receptor heteromers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492915/
https://www.ncbi.nlm.nih.gov/pubmed/25560761
http://dx.doi.org/10.1038/mp.2014.166
work_keys_str_mv AT frederickaliyal evidenceagainstdopamined1d2receptorheteromers
AT yanohideaki evidenceagainstdopamined1d2receptorheteromers
AT trifilieffpierre evidenceagainstdopamined1d2receptorheteromers
AT vishwasraoharshadd evidenceagainstdopamined1d2receptorheteromers
AT biezonskidominik evidenceagainstdopamined1d2receptorheteromers
AT meszarosjozsef evidenceagainstdopamined1d2receptorheteromers
AT sibleydavidr evidenceagainstdopamined1d2receptorheteromers
AT kellendonkchristoph evidenceagainstdopamined1d2receptorheteromers
AT sonntagkaic evidenceagainstdopamined1d2receptorheteromers
AT grahamdevonl evidenceagainstdopamined1d2receptorheteromers
AT colbranrogerj evidenceagainstdopamined1d2receptorheteromers
AT stanwoodgreggd evidenceagainstdopamined1d2receptorheteromers
AT javitchjonathana evidenceagainstdopamined1d2receptorheteromers